P127 Efficacy and safety of trastuzumab biosimilar Abdi Ibrahim in the neoadjuvant setting for HER2 positive breast cancer: about 40 cases.
| Autor: | Nèche, N., Kouadri, N., Djedi, H. |
|---|---|
| Předmět: | |
| Zdroj: | Breast; 2023 Supplement, Vol. 68, pS64-S64, 1p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|
Full Text from ScienceDirect